Apr 23, 2019 - Health

Rochester Drug Cooperative could face the first criminal opioid-related charges

Caitlin Owens

In this image, white circular pills spill out of an orange pill bottle and onto a table. — Oxycodone. Photo: Education Images/UIG via Getty Images

Rochester Drug Cooperative may become the first major drug distributor to face criminal charges over the opioid epidemic, the New York Times reports.

What's happening: The Southern District of New York and the Drug Enforcement Agency are wrapping up an investigation that began with an examination of potential crimes that included fraud and drug violations. It's unclear what charges would be brought against Rochester.

The big picture: Other major distributors are involved in other civil lawsuits across the country.

They allege that distributors created systems to evade regulators as they continued to shuttle around massive amounts of opioids.

The bottom line: The three largest distributors failed to adequately monitor suspicious opioid orders at the onset of the epidemic, and have since failed to build systems that prevent abuse, the NYT writes.

These distributors — Cardinal Health, McKesson and AmerisourceBergen — sold 1.6 billion oxycodone pills in New York between 2010 and 2018.

Go deeper:

Add Axios on Google

Rochester Drug Cooperative could face the first criminal opioid-related charges

What to read next